vancomycin has been researched along with Metabolic Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bakker, GJ; Bekkering, S; Cani, PD; Dallinga-Thie, GM; de Clercq, NC; Groen, AK; Hartstra, AV; Herrema, H; Kemper, EM; Koopen, AM; Kroon, J; Meessen, ECE; Nieuwdorp, M; Scheithauer, TP; Schnitzler, JG; Soeters, MR; van Raalte, DH; Winkelmeijer, M | 1 |
| Ackermans, MT; Blaak, EE; Dallinga-Thie, GM; de Vos, WM; Fuentes, S; Groen, AK; Hoekstra, JB; Holleman, F; Holst, JJ; Jonker, L; Kema, IP; Knaapen, M; Knop, FK; Kootte, RS; Nieuwdorp, M; Out, C; Reijnders, D; Reuling, I; Romijn, JA; Serlie, MJ; Soeters, MR; Stroes, ES; van der Ley, C; van Nood, E; Vrieze, A; Zoetendal, EG | 1 |
2 trial(s) available for vancomycin and Metabolic Syndrome
| Article | Year |
|---|---|
Oral vancomycin treatment does not alter markers of postprandial inflammation in lean and obese subjects.
Topics: Adult; Anti-Bacterial Agents; Dietary Fats; Gastrointestinal Microbiome; Humans; Inflammation; Lipopolysaccharides; Male; Metabolic Syndrome; Middle Aged; Monocytes; Obesity; Postprandial Period; Vancomycin | 2019 |
Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity.
Topics: Administration, Oral; Adult; Aged; Animals; Anti-Bacterial Agents; Bile Acids and Salts; Feces; Glucose; Humans; Insulin Resistance; Intestines; Male; Metabolic Syndrome; Mice; Microbiota; Middle Aged; Obesity; Single-Blind Method; Vancomycin | 2014 |